[ Back to EurekAlert! ]

Contact: Rex Graham
ragraham@sandiegobiotechnology.com
858-232-2706
San Diego Biotechnology Connection

Adenovector with Human FGF-4 Gene

Caption: Cardium Therapeutics' Generx DNA-based product candidate has already been shown to be safe in clinical studies involving 650 patients at more than 100 medical centers.

Credit: ęCardium Therapeutics

Usage Restrictions: Use with photo credit

Related news release: Delivery of gene-therapy for heart disease boosted 100-fold; now in 100-patient trial


[ Back to EurekAlert! ]